Dr. Arand D. Pierce, MD

Dr. Pierce practices at Presbyterian Hospital in Albuquerque, New Mexico, part of Presbyterian Healthcare Services.

Dr. Pierce's NPI, 1295874295, was assigned on February 6, 2007. Dr. Pierce graduated from The University of New Mexico School of Medicine in 2006. Dr. Pierce holds New Mexico license MD2010-0037.

Dr. Pierce's primary practice is Presbyterian Hospital, at 1100 Central Avenue SE, Albuquerque, NM 87106 in Bernalillo County. The practice phone is (505) 724-8386.

Dr. Pierce's primary practice is Presbyterian Hospital in Albuquerque, New Mexico, part of Presbyterian Healthcare Services. Dr. Pierce is also affiliated with Presbyterian Santa Fe Medical Center. The medical group on file is Presbyterian Medical Group. Dmand AI also links Dr. Pierce to 2 more group practices and clinics and 1 medical group, each named with a free account. Dr. Pierce's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Pierce practices, 4 sites in all. Vendor and product names are available with a free account.

Anatomic pathology and clinical pathology is Dr. Pierce's primary specialty in the NPI Registry, under taxonomy code 207ZP0102X. Dr. Pierce is board certified in blood banking/transfusion medicine by the American Board of Pathology. Dr. Pierce is licensed in New Mexico.

CMS data shows 53 Medicare services from Dr. Pierce across 3 procedure codes in 2024, for 91 Medicare patients. Medicare paid $3,547 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 91 Medicare patients who saw Dr. Pierce in 2024. The largest group is 75 to 84, with 38 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 14% are also on Medicaid. Their average risk score is 1.48, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Pierce's median patient age at 55, with 80% women.

In 2024, Dr. Pierce wrote 79 Medicare Part D claims for 16 patients. CMS names the drug for 72 of them, across 4 drugs with 11 or more claims each, at $85,558 in total drug cost. In 2022, CMS named 29 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Pierce for performance year 2024, reported as part of a group. Dr. Pierce accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Pierce as offering telehealth.

Dmand AI links 2 papers to Dr. Pierce.

Dmand AI links Dr. Pierce to 1 clinical trial. Conditions studied include Thromboembolism and Respiratory Insufficiency.

CMS Open Payments shows 2 general payments to Dr. Pierce from 2 drug and device companies from 2018 to 2019. Food and beverage make up the largest share, 100% of the total. Portola Pharmaceuticals, LLC paid the most, $97.

Dr. Pierce graduated from The University of New Mexico School of Medicine in 2006.

Dr. Pierce is in network with 6 carriers, including Blue Cross Blue Shield of Michigan, Cigna and HCSC. Medicare plans come from the most carriers, 6. Check the plan with the practice before a visit.